Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080285 | SCV000112180 | benign | not specified | 2013-03-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080285 | SCV000309685 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000080285 | SCV000523002 | benign | not specified | 2016-01-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001527266 | SCV001738224 | benign | Miyoshi muscular dystrophy 1 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055165 | SCV002339626 | benign | Qualitative or quantitative defects of dysferlin | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001795105 | SCV005240220 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000080285 | SCV002034600 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001795105 | SCV002036460 | likely benign | not provided | no assertion criteria provided | clinical testing |